Shanghai Vcanbio Jisheng Cell Technology Co., Ltd. announced that it will receive CNY 20 million in an equity round of funding on November 8, 2023. The transaction will include participation from returning investor, from returning investor Vcanbio Cell & Gene Engineering Corp., Ltd. The transaction has been approved at the fifth extraordinary meeting of Vcanbio Cell & Gene Engineering Corp., Ltd's eleventh session of the board of directors.